-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on WAVE Life Sciences, Raises Price Target to $27

Benzinga·03/25/2026 14:18:08
Listen to the news
Mizuho analyst Salim Syed maintains WAVE Life Sciences (NASDAQ:WVE) with a Outperform and raises the price target from $22 to $27.